SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sportfish who wrote (1661)2/23/2000 7:44:00 PM
From: SgtPepper  Read Replies (1) of 1754
 
"Good News" announced on CNBC was that competitor BEAM also cut prices. Go figure.

WALTHAM, Mass.--(BW HealthWire)--Feb. 23, 2000--Summit
Technology, Inc. (NASDAQ: BEAM.O) announced today that the Company will
institute a tiered pricing program for customers effective
immediately. Summit's Apex Plus/Infinity product will be value priced
and will carry a per procedure licensing fee of $100. The emphasis
disc used by clinicians for astigmatism and hyperopia corrections will
be priced at $25. There is no administrative charge imposed in
connection with the purchase of the card used to activate the system.
The Autonomous LADARVision(R) system, the only small spot, scanning
laser with a FDA approved eyetracker, will continue to command a
premium price. The per procedure license fee for the LADARVision(R)
system will be reduced to $150 for purchased units. Additionally, the
Company will adjust its current per procedure pricing model for its
existing customers to bring them in line with the new pricing model.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News